Beyond the Printer: The Mission to Make Personalized Medicine Accessible to Everyone | CurifyLabs Podcast Series
- 30m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode explores how Curify Labs is transforming non-sterile compounding and personalized medicine through its technology platform. The guests, CEO and co-founder Sharlata and co-founder and pharmacist Nicholas, discuss their journey of building an automated, standardized ecosystem for pharmacies, starting from European markets and expanding into the United States. They explain how the platform addresses manual inefficiencies, staff shortages, and quality control challenges, enabling pharmacists to produce medications up to nine times faster. The discussion highlights the importance of customer collaboration, upcoming trends like peptide and hormone replacement therapy support, and the future vision of ultra-personalized medicine.
- Compounders can increase efficiency and productivity by utilizing technology that makes operations up to nine times faster. 11:33
- Standardized automated workflows ensure consistent quality and recipe execution across pharmacies in different regions. 12:46
- Pharmacies can adopt the Create software function to customize formulations when specific items are not already in the library. 21:23
Chapters
- 0:00Podcast Intro and Market Overview
The host introduces the episode, shares compounding market size and sets the stage for Curify Labs’ mission.
- 0:59Curify Labs Introduction
Todd Urey welcomes guests Sharlata and Nicholas, explaining Curify Labs’ background and purpose.
- 2:03Founders’ Backgrounds and Vision
Sharlata and Nicholas discuss their personal histories, the company’s founding, and their commitment to meaningful pharmacy solutions.
- 5:11Origins of Curify Labs
The founders explain what gaps in traditional compounding inspired the creation of Curify Labs and their desire to modernize the field.
- 7:43Technology Development and Customer‑Centric Approach
They describe their rapid‑iteration, fail‑fast methodology and how they work directly with pharmacies to build usable tech.
- 9:23Personalized Medicine and Ultra‑Personalization
Curify Labs’ goal to broaden personalization beyond standard compounding, including peptides and precise dosing, is outlined.
- 12:00Validation, Standardization, and Quality Assurance
They discuss ISO, SOC 2, and rigorous validation to ensure consistent, high‑quality compounded medications.
- 15:32Ecosystem vs. Standalone Device
The team explains how their platform integrates hardware, software, and validated processes into a comprehensive ecosystem.
- 19:15Expanding Product Offerings and Customer Feedback Loop
Curify Labs prioritizes new dosage forms based on pharmacy input, adding a create‑your‑own feature for flexibility.
- 28:38Closing and Call to Action
Todd wraps up, invites listeners to visit Curify Labs, and emphasizes the company’s impact on pharmacy practice.
Highlights
- 2:03
Third Company and Love of Lifestory
Sharlata shares her background as a repeat founder and explains why Curify Labs feels like the most meaningful and rewarding venture of her career.
- 3:08
Ten Years of Academic Researchstory
Nicholas describes his background as a pharmaceutical professor and how a decade of looking into 3D printing led to co-founding Curify Labs in 2021.
- 7:43
Failing Fast and Testing Rapidlystrategy
Sharlata explains how the team worked directly with customers across multiple countries to test, fail fast, and refine their technology based on real-world feedback.
- 11:33
Nine Times Faster Processingdata
Sharlata highlights how the technology helps pharmacies save time, increase efficiency, and handle a higher volume of prescriptions.
- 15:41
More Than Just a Printerinsight
The guests emphasize that a standalone 3D printer creates headaches, which is why they built a complete ecosystem covering the entire workflow.
- 18:18
Removing Variability Through Validationinsight
Nicholas explains how extensive lab studies and validated five-minute mixing times remove historical guesswork and variability from compounding.
- 25:29
Enabling Ultra-Personalized Medicineinsight
Sharlata and Nicholas discuss how combining pharmacogenomics and accurate dosing allows independent compounders to deliver true ultra-personalized medicine.
Quotes
“$5.13 billion. That's the market size of the United States compounding market as of 2023.”
Unnamed speaker · 0:00
Sponsored segments
- Curify Labs 0:47–30:26
About this episode
What if the future of personalized medicine wasn't just about developing new treatments, but transforming how pharmacies prepare medications for individual patients? In this opening episode of the CurifyLabs Podcast Series, we sit down with founders Charlotta Topelius and Niklas Sandler Topelius to explore the inspiration, challenges, and mission behind CurifyLabs. From recognizing limitations in traditional pharmaceutical compounding to envisioning a more standardized, efficient, and scalable approach, the founders share how their commitment to innovation evolved into a mission to make personalized medicines more accessible to patients and the pharmacists who serve them. The conversation goes beyond 3D printing to explore why CurifyLabs developed an integrated compounding ecosystem rather than a standalone device. By bringing together validated formulations, specialized excipient bases, automated mixing and dispensing, quality-control capabilities, and digital batch documentation, CurifyLabs aims to help pharmacies modernize compounding while preserving the essential expertise and clinical judgment of pharmacists. Charlotta and Niklas also share their perspectives on the next generation of personalized medicine, the importance of pharmacist-driven innovation, and their vision for a future where technology helps make individualized treatment more practical, consistent, and accessible. Key Topics Discussed The origin story and entrepreneurial vision behind CurifyLabs. Why personalized medicine needs new approaches to pharmaceutical compounding. The mission to make individualized medications more accessible. Why CurifyLabs developed a complete compounding ecosystem instead of just a pharmaceutical printer. How automation, validated formulations, and standardized workflows can support quality and consistency. The evolving role of pharmacists in technology-enabled personalized medicine. How pharmacist feedback and research influence future innovation. The founders' vision for the next five years of pharmaceutical compounding. The Big Takeaway: CurifyLabs is working toward a future in which personalized medicine is not the exception, but an increasingly practical part of everyday pharmacy care. Its mission goes beyond the technology itself: empowering pharmacists with tools and processes that support individualized treatment while keeping patient needs at the center of innovation. Learn more: https://curifylabs.com/ Pharmacy Podcast NetworkAmplifying the Voice of Pharmacists and Our Profession.
Transcript
4,523 words · 4 speakers
Topics
- United States
- Alliance of Pharmacy Compounding
Page updated · transcript and summary are machine-generated